☆ 4.7 Article

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

ANNALS OF INTERNAL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Medicine, General & Internal

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

Marie Joelle Jabagi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Mathematical & Computational Biology

A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety

Yonas Ghebremichael-Weldeselassie et al.

Summary: This paper proposes a modified self-controlled case series (SCCS) method to study the safety of COVID-19 vaccines. By using case studies and simulations, the authors investigate the biases that may arise from event-dependence and high event-related mortality, and present a new testing method.

STATISTICS IN MEDICINE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview

Amir Abbas Shiravi et al.

Summary: SARS-CoV-2, the virus that causes COVID-19, has led to a global pandemic. Vaccines like Pfizer and Moderna have been proven safe and effective, but have also been linked to rare, sometimes fatal cardiovascular side effects. However, the benefits of these vaccines in ending the pandemic and reducing mortality rates outweigh any risk of rare cardiovascular complications.

CARDIOLOGY AND THERAPY (2022)

添加到收藏夹

Article Medicine, General & Internal

Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study

Celine Sze Ling Chui et al.

Summary: This study evaluates the association between thromboembolic events and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. The results indicate a possible safety signal for hemorrhagic stroke after BNT162b2 vaccination, but there is no statistically significant risk for thromboembolic events for both vaccines. The incidence of thromboembolic events or hemorrhagic stroke following vaccination is lower than that among SARSCoV-2 test positive cases. Vaccination against COVID-19 remains an important public health intervention.

ECLINICALMEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database

Rimple Kaur et al.

International Journal of General Medicine (2021)

添加到收藏夹

Article Immunology

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data

Luigi Cari et al.

Summary: The study found that the frequency of severe adverse events in ChAdOx1 nCoV-19 and Ad26.COV2.S vaccine recipients is significantly higher compared to BNT162b2 COVID-19 vaccine recipients, suggesting potential risks associated with virus-based vaccines. However, the frequency of SAE types varies among recipients in different age groups.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

Anton Pottegard et al.

Summary: This study assessed rates of cardiovascular and haemostatic events in Denmark and Norway after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S, finding increased rates of venous thromboembolic events among recipients. Despite slightly higher rates of thrombocytopenia/coagulation disorders and bleeding, the overall safety outcomes were largely reassuring.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

Nicola P. Klein et al.

Summary: This study conducted interim analysis of safety surveillance data of mRNA COVID-19 vaccines and found that the incidence of selected serious outcomes within 1-21 days post-vaccination was not significantly higher compared with 22-42 days post-vaccination. Surveillance is ongoing despite wide confidence intervals for many outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study

Ioannis Katsoularis et al.

Summary: This study in Sweden quantified the risk of acute myocardial infarction and ischaemic stroke associated with COVID-19, finding a significant correlation.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

C. R. Simpson et al.

Summary: Analysis of data from the EAVE II cohort in Scotland has shown that a first dose of the ChAdOx1 nCoV-19 vaccine may be associated with increased risks of idiopathic thrombocytopenic purpura, arterial thromboembolic events, and hemorrhagic events. However, there were no positive associations found between the BNT162b2 vaccine and these adverse events.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

Julia Hippisley-Cox et al.

Summary: The study found increased risks of haematological and vascular events leading to hospital admission or death within short time intervals after first doses of the ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines. The risks of these events were higher and more prolonged after SARS-CoV-2 infection compared to vaccination in the same population.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Pediatrics

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020

Marion Taine et al.

Summary: During the first lockdown in France, there were significant decreases in the dispensation of both priming doses and boosters for infants, particularly for MMR priming doses and Men-C-C boosters. Although vaccination counts slightly increased after the lockdown, they remained below the expected numbers.

FRONTIERS IN PEDIATRICS (2021)

添加到收藏夹

Article Health Care Sciences & Services

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people

Laura Semenzato et al.

Summary: In France, the risk of COVID-19 hospitalization and mortality is associated with age, gender, social deprivation, and various chronic health conditions. Down syndrome, mental retardation, kidney transplantation, lung transplantation, end-stage renal disease, and active lung cancer show the strongest associations with COVID-19 risk.

LANCET REGIONAL HEALTH-EUROPE (2021)

添加到收藏夹

Article Clinical Neurology

Seasonal influenza vaccine and Guillain-Barre syndrome: A self-controlled case series study

Clemence Grave et al.

NEUROLOGY (2020)

添加到收藏夹

Article Immunology

The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation

Julia Stowe et al.

VACCINE (2016)

添加到收藏夹

Article Immunology

Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles/mumps/rubella immunization

Matthieu Hanf et al.

VACCINE (2013)

添加到收藏夹

Article Mathematical & Computational Biology

Case series analysis for censored, perturbed, or curtailed post-event exposures

C. Paddy Farrington et al.

BIOSTATISTICS (2009)

添加到收藏夹

Article Statistics & Probability

Large-scale simultaneous hypothesis testing: The choice of a null hypothesis

B Efron

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.